Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000372921

Medchemexpress LLC Larotinib mesylate hydrate | 2097129-93-4 | C26H36ClFN4O11S2 | 100 MG
SDP

Catalog No. 5000372921
Encompass_Preferred

Larotinib mesylate hydrate is a potent, broad-spectrum, and orally active tyrosine kinase inhibitor (TKI) with EGFR as the main target with an IC50 of 0.6 nM. This compound is intended for research use only.

  • Inhibits EGFRL861Q (IC50: 0.423 nM)
  • Inhibits EGFRL858R (IC50: 0.563 nM)
  • Inhibits EGFR (WT) (IC50: 0.611 nM)
  • Inhibits EGFRT790M (IC50: 45.2 nM)
  • Inhibits HER4 (IC50: 84 nM)
  • Inhibits BLK (IC50: 102 nM)
  • Inhibits IRAK-1 (IC50: 167 nM)
  • Inhibits BTK (IC50: 196 nM)
  • Inhibits HER2 (IC50: 253 nM)

Catalog No. 50-003-72921 Supplier Medchemexpress LLC Supplier No. HY153110A100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Larotinib mesylate hydrate is a potent, broad-spectrum, and orally active tyrosine kinase inhibitor (TKI) with EGFR as the main target with an IC50 of 0.6 nM. This compound is intended for research use only.

  • Inhibits EGFRL861Q (IC50: 0.423 nM)
  • Inhibits EGFRL858R (IC50: 0.563 nM)
  • Inhibits EGFR (WT) (IC50: 0.611 nM)
  • Inhibits EGFRT790M (IC50: 45.2 nM)
  • Inhibits HER4 (IC50: 84 nM)
  • Inhibits BLK (IC50: 102 nM)
  • Inhibits IRAK-1 (IC50: 167 nM)
  • Inhibits BTK (IC50: 196 nM)
  • Inhibits HER2 (IC50: 253 nM)

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.